DigestRedComo funciona
Red
/
Empresas
Ga
No verificado

Galderma

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaSaludSanidad

53 Comunicados de prensa

Ver todos los comunicados de prensa
16/04/2026
Industria
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Galderma Launches New Alastin Regenerating Skin Nectar with TriHex+™, Powered by Its Next-Generation TriHex Technology® Regenerative Platform
Fuente
Galderma
Editor
Business Wire
1.00
0
09/04/2026
Industria
Salud
Ir de compras
Fitness
Medicina - Varios
Farmacéutica
Biotecnología
Interim Data From Two Ongoing Investigator-initiated Trials Highlight the Role of Sculptra® and Restylane® in Addressing Aesthetic Changes Associated With Weight Loss Medications and Menopause
Fuente
Galderma
Editor
Business Wire
1.00
0
07/04/2026
Industria
Biotecnología
Salud
Cosmética
Venta al público/Minorista
Farmacéutica
Galderma Debuts ALASTIN Signature Practices in Partnership With Leading Aesthetic Practices to Elevate Regenerative, Peri-Procedural Skincare
Fuente
Galderma
Editor
Business Wire
1.00
0
24/03/2026
Eventos
Industria
Ciencia
Técnica
Higiene alimentaria
Medicina - Varios
Biotecnología
Sanidad
Farmacéutica
Salud
AAD 2026: Galderma Showcases Latest Evidence Supporting Its Full-Spectrum, Science-Driven Solutions for Diverse Skin Needs
Fuente
Galderma
Editor
Business Wire
1.00
0
23/03/2026
Multimedia
Industria
Cosmética
Venta al público/Minorista
Salud
Higiene alimentaria
Sanidad
Farmacéutica
Biotecnología
Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing
Fuente
Galderma
Editor
Business Wire
1.00
0
20/03/2026
Web y redes sociales
Mercado laboral
Acciones y Obligaciones
Cosmética
Venta al público/Minorista
Salud
Sanidad
Galderma Publishes Invitation and Agenda for Its 2026 Annual General Meeting
Fuente
Galderma
Editor
Business Wire
1.00
0
11/03/2026
Finanzas
Cosmética
Venta al público/Minorista
Salud
Sanidad
Galderma Buys Back Shares Worth CHF 232 Million in the Context of Accelerated Bookbuild Offering
Fuente
Galderma
Editor
Business Wire
1.00
0
09/03/2026
Industria
Ciencia
Sanidad
Salud
Cosmética
Venta al público/Minorista
Galderma Introduces Cetaphil AM/PM Antioxidant Serums, a New Science-Driven Defense and Recovery System for Sensitive Skin
Fuente
Galderma
Editor
Business Wire
1.00
0
27/02/2026
Multimedia
Industria
Salud
Ciencia
Farmacéutica
Medicina - Varios
Galderma’s Nemluvio® (nemolizumab) Demonstrates Long-Term Disease Control in Prurigo Nodularis up to Three Years
Fuente
Galderma
Editor
Business Wire
1.00
0
25/02/2026
Multimedia
Industria
Material médico sanitario
Salud
Higiene alimentaria
Sanidad
Farmacéutica
Galderma Announces Triple Approval of New State-of-the-Art Restylane® Syringe in the EU, the U.S., and Canada, Reaffirming the Company’s Position at the Forefront of Injectable Aesthetics
Fuente
Galderma
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0